摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S,3S,4R)-2-azido-5-propoxypentane-1,3,4-triol | 1375103-24-4

中文名称
——
中文别名
——
英文名称
(2S,3S,4R)-2-azido-5-propoxypentane-1,3,4-triol
英文别名
——
(2S,3S,4R)-2-azido-5-propoxypentane-1,3,4-triol化学式
CAS
1375103-24-4
化学式
C8H17N3O4
mdl
——
分子量
219.241
InChiKey
CFCCAMGGQHAZPR-RNJXMRFFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.19
  • 重原子数:
    15.0
  • 可旋转键数:
    8.0
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    118.68
  • 氢给体数:
    3.0
  • 氢受体数:
    5.0

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis and biological evaluation of truncated α-galactosylceramide derivatives focusing on cytokine induction profile
    摘要:
    A series of truncated analogs of alpha-galactosylceramide with altered ceramide moiety was prepared, and evaluated for Th2-biased response in the context of IL-4/IFN-gamma ratio. Phytosphingosine-modified analogs including cyclic, aromatic and ethereal compounds as well as the C-glycoside analog of OCH (2) with their cytokine inducing profile are disclosed. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.03.025
  • 作为产物:
    描述:
    (2R,3R,4R)-1,3,4-trihydroxy-5-propoxypentan-2-yl methanesulfonate 在 sodium azide 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 3.0h, 以119 mg的产率得到(2S,3S,4R)-2-azido-5-propoxypentane-1,3,4-triol
    参考文献:
    名称:
    Synthesis and biological evaluation of truncated α-galactosylceramide derivatives focusing on cytokine induction profile
    摘要:
    A series of truncated analogs of alpha-galactosylceramide with altered ceramide moiety was prepared, and evaluated for Th2-biased response in the context of IL-4/IFN-gamma ratio. Phytosphingosine-modified analogs including cyclic, aromatic and ethereal compounds as well as the C-glycoside analog of OCH (2) with their cytokine inducing profile are disclosed. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.03.025
点击查看最新优质反应信息